Chapman's Eat Market in German Village to close after five years
Husband-and-wife duo B.J. Lieberman and Bronwyn Haines announced on social media last week that Chapman's at 739 S. Third St., which opened in 2020, is permanently shuttering at the end of August. The couple said, as the restaurant nears its fifth birthday and the end of the lease, they 'were faced with the difficult decision on whether or not to continue.'
Ohio horror museum featuring 'last meal' restaurant reveals opening date
'Inevitably, we chose to finish our story on a high note, celebrating all that we have accomplished and created over the years and within these walls, including the team that we've built and the memories we made,' the social media post said. Watch a NBC4 report from Chapman's 2020 opening in the video player above.
Lieberman was one of two Columbus chefs named among the semifinalists for last year's James Beard Awards, prestigious national honors that recognize talent in the culinary and food media industries. He and Haines also launched Ginger Rabbit at 17 Buttles Ave. in 2022, and most recently opened Metsi's Wood-Fired Italian at 36 E. Lincoln St. last month.
Chapman's, named among the New York Times' best U.S. restaurants in 2021, is home to a curated menu of appetizers, salads, pastas and entrees, like Levantine cod, smoked Cornish game hen, and a 6-ounce beef tenderloin. Sides, like beef fat fries and wilted green beans, round out the menu.
Granville's historic Buxton Inn listed for $5.85 million
Lieberman and Haines said Chapman's final day of service will be announced in August. Until then, the restaurant is open 5 to 9 p.m. Sunday through Thursday, and 5 to 10 p.m. Friday and Saturday.
'We hope each and every one of you will join us for a final meal before we say goodbye — whether it's your last general tsos cauliflower, khao soi or maple budino, we look forward to serving and celebrating with you,' the social media post said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
10 hours ago
- The Hill
Arizona woman sentenced over North Korea tech-worker fraud scheme
An Arizona woman was sentenced to more than eight years in prison on Thursday after she pleaded guilty to helping North Korean tech workers secure remote jobs with hundreds of U.S. firms using false identities. Christina Marie Chapman, 50, of Litchfield Park, Ariz., helped North Korean workers gain IT positions at 309 U.S. businesses as part of a scheme that reaped in more than $17 million, mostly for Pyongyang, according to a Justice Department statement. The department said much of the income was falsely reported to the IRS and Social Security Administration using the names of actual U.S. citizens, who had their identities stolen or borrowed. The scheme created false tax liabilities for 68 Americans whose identities were compromised, according to the DOJ. 'The impacted companies included a top-five major television network, a Silicon Valley technology company, an aerospace manufacturer, an American car maker, a luxury retail store, and a U.S media and entertainment company,' the DOJ said in its release. In the wake of the scheme, U.S. Attorney Jeanine Ferris Pirro urged companies to be more vigilant when vetting remote workers. 'North Korea is not just a threat to the homeland from afar. It is an enemy within. It is perpetrating fraud on American citizens, American companies and American banks. It is a threat to Main Street in every sense of the word,' Pirro said in a statement. 'The call is coming from inside the house. If this happened to these big banks, to these Fortune 500, brand name, quintessential American companies, it can or is happening at your company. Corporations failing to verify virtual employees pose a security risk for all. You are the first line of defense against the North Korean threat,' she added. Last year, the Justice Department made multiple arrests in connection to foreign remote workers who gained U.S. employment with stolen identities. In response to the latest scheme, U.S. District Court Judge Randolph D. Moss ordered Chapman to serve three years of supervised release in addition to the 102-month prison sentence. She will also be required to forfeit nearly $285,000 that was to be paid to the North Koreans and pay a judgement of more than $175,000. Chapman pleaded guilty on Feb. 11 in the District of Columbia to conspiracy to commit wire fraud, aggravated identity theft and conspiracy to launder monetary instruments, the DOJ said.
Yahoo
13 hours ago
- Yahoo
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)
In a market dominated by headlines about artificial intelligence (AI), cloud computing, and digital platforms, it is easy to overlook some of the most transformative developments in the life sciences. Cathie Wood, CEO of ARK Invest and known for her bold bets on disruptive innovation, has her sights set on Illumina (ILMN), a company that connects science and technology. On July 22, Wood's ARK's Genomic Revolution ETF (ARKG) bought 31,265 shares of Illumina, amounting to nearly $2.98 million, bringing the total investment in the company to $32 million. It is the ETF's 15th largest holding, comprising 2.8% of the overall portfolio. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Let's find out if investors should follow Wood's lead and buy Illumina stock here. A High-Conviction Bet on the Future of Medicine Valued at $16.6 billion, Illumina is a biotechnology company that specializes in genome sequencing, or the process of reading and analyzing DNA. It manufactures machines (sequencers), software, and chemical kits that are used to decode the genetic material (DNA) of humans, animals, plants, and bacteria. Illumina's technology is used in hospitals and clinics, by cancer researchers, pharmaceutical companies, agricultural scientists, academics, and research institutions, among others. Some of its products include the NovaSeq X Series, iScan System, iSeq 100 System, Illumina DNA Prep, Illumina Stranded mRNA Prep, and many others. Illumina's stock price has dropped significantly since its 2021 highs, falling from above $500 to around the $100-$120 range by mid-2025. Much of this decline can be attributed to a series of self-inflicted wounds, most notably its controversial acquisition of cancer detection company Grail. However, with the Grail divestment in 2024 and a new CEO, Jacob Thaysen, in charge, Illumina appears to be refocusing on its core business of making genome sequencing cheaper, faster, and more accessible. Why the Timing Matters Now Wood is known for buying when volatility is high, particularly when she believes the market has overcorrected due to near-term concerns. Following the Grail divestment, leadership change, and a multi-quarter slump in revenue growth, investor sentiment is bearish on Illumina stock, explaining the nearly 20% drop year-to-date. However, Wood saw this as an opportunity to stock up on this rising genomic star. Illumina's financial performance appears to be stabilizing. For a growth investor like Wood, who prefers to overlook short-term earnings volatility in favor of long-term potential, these improvements are a welcome sign that the company is on the right track. In the first quarter, while revenue growth dipped slightly by 1.4%, the company improved its margins and reduced unnecessary expenses. Illumina exceeded revenue expectations and reaffirmed full-year guidance. Adjusted gross margins increased to 67.4% as a result of improved manufacturing efficiency and lower R&D costs. Adjusted earnings per share fell to $0.97 from $0.98 in the prior year's quarter. Remaining performance obligations (RPO) totaled $891 million, of which Illumina expects to generate 83% in revenue over the next year. With a reasonable debt-equity ratio of 0.63x, Illumina's balance sheet is stable. The company also generated a positive free cash flow of $208 million during the quarter. Illumina will report its second-quarter earnings on July 31. Analysts expect revenue of $1.05 billion on earnings per share of $1.01. Analysts predict a 3% drop in revenue for the full year but earnings growth of 72.9% to $4.24 per share, with an additional 9.5% increase expected in 2026. Another factor that may have influenced ARK's decision to increase its stake in Illumina is valuation. The stock is currently trading at 22 times forward earnings for 2026 and three times forward sales. Illumina has the world's largest genomics dataset, giving the company a competitive advantage. Many of Illumina's future revenue streams, including large-scale population sequencing contracts and new clinical applications in oncology and rare diseases, are not fully priced into current projections. This reasonable valuation represents a buying opportunity for a growth stock with excellent long-term prospects. What Is Wall Street Saying About Illumina Stock? Overall, the consensus on Illumina stock is a 'Moderate Buy.' Of the 22 analysts covering the stock, nine recommend a 'Strong Buy,' one suggests a 'Moderate Buy,' nine rate it a 'Hold,' one says it is a 'Moderate Sell,' and two have given it a 'Strong Sell' rating. The stock is trading close to its average target price of $106.83. However, the high price estimate of $185 suggests a rally of over 76.8% from current levels. The Key Takeaway Wood's stake in Illumina is a calculated investment based on extensive research, long-term vision, and a firm belief in the power of genomics to transform healthcare. Now, with a lower cost structure, a clear path back to profit growth, and exciting new products on the market, Illumina is poised for a turnaround. For investors with patience and a long horizon, Illumina stock represents a one-of-a-kind opportunity to invest in genomic infrastructure. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
CNN
15 hours ago
- CNN
Arizona woman sentenced in North Korean tech worker scheme
A woman in Arizona was sentenced Thursday to more than 8 years in prison for orchestrating a complex fraud scheme to help North Korean cyber operatives pose as Americans and obtain remote IT jobs at hundreds of US companies, including Fortune 500 corporations. The plot, described by the Department of Justice as one of the largest North Korean IT worker fraud schemes, used the stolen identities of 68 Americans, defrauded more than 300 US businesses and generated more than $17 million in revenue –– funds that could benefit the nuclear-armed North Korean regime, the department said in a release. Christina Chapman, 50, pleaded guilty in February after being accused of operating a 'laptop farm' from her home, where she 'received and hosted' company-issued computers on behalf of foreign IT workers to trick companies into believing the workers were living in the US. She was charged with nine counts, including conspiracy to commit wire fraud and aggravated identity theft. In its statement, the DOJ said North Korea has deployed thousands of highly skilled IT workers around the world, including to the US, to circumvent controls employed by US companies to prevent illegal hirings by enlisting the assistance of US-based collaborators. The DOJ said Chapman shipped 49 laptops and other devices to various locations abroad, including a city in China near the North Korean border. Authorities found more than 90 laptops in her home in an October 2023 search. Chapman also received and forged payroll records using stolen identities. Funds were deposited into her personal US accounts and then transferred to individuals overseas. Among the companies affected by the scheme are Fortune 500 corporations, a major national TV network, an aerospace manufacturer, an American car maker and a luxury retail store, the May indictment read, without naming the companies. Officials said that foreign IT workers unsuccessfully attempted to obtain employment at two US government agencies. The State Department and other agencies issued in 2022 a warning about schemes, where North Korean IT workers, posing as from other nationalities, offered to work remotely and applied for jobs in electronic gaming, IT support, and artificial intelligence, among other sectors. Some of these IT workers work closely with North Korean hackers, who are also a rich source of revenue for the regime, according to experts who spoke with CNN. About half of North Korea's missile program has been funded by cyberattacks and cryptocurrency theft, a White House official said in 2024. 'By directing its IT workers to gain employment at Western companies, North Korea has weaponized its tech talent and created the ultimate insider threat,' Michael Barnhart, a North Korea specialist at Google-owned cybersecurity firm Mandiant, told CNN in 2024. 'These operatives bypass sanctions by diverting their paychecks to help fund North Korea's nuclear program. Simultaneously, they're providing a foothold into major organizations for North Korea's more advanced threat groups,' Barnhart said.
